Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA trial

A. M. Oza, U. A. Matulonis, S. Malander, J. Sehouli, J. M. del Campo, D. Berthon-Rigaud, S. Banerjee, G. Scambia, J. S. Berek, Bente Lund, A. V. Tinker, F. Hilpert, I. Palacio Vázquez, V. D’hondt, B. Benigno, D. M. Provencher, J. Buscema, S. Hudgens, S. Agarwal, M. R. Mirza

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer930O
TidsskriftAnnals of Oncology
Vol/bind28
Udgave nummerSuppl. 5
Sider (fra-til)330
Antal sider1
ISSN0923-7534
StatusUdgivet - 2017
BegivenhedEuropean Society for Medical Oncology (ESMO) 2017: Integrating science into oncology for a better patient outcome - Madrid, Spanien
Varighed: 8 sep. 201712 sep. 2017
http://www.esmo.org/Conferences/ESMO-2017-Congress

Konference

KonferenceEuropean Society for Medical Oncology (ESMO) 2017
LandSpanien
ByMadrid
Periode08/09/201712/09/2017
Internetadresse

Citationsformater